Figure 2
Impact of AREG mRNA levels on cetuximab-treated patient survival by KRAS tumour mutation. (Blue line: AREG-high, Red line: AREG-low). a) KRAS wild-type (p=0.0005), b) KRAS mutated (p=0.64).
Figure 2 | BMC Cancer
Impact of AREG mRNA levels on cetuximab-treated patient survival by KRAS tumour mutation. (Blue line: AREG-high, Red line: AREG-low). a) KRAS wild-type (p=0.0005), b) KRAS mutated (p=0.64).